Bortezomib (Bortezomib)

**Product type:** Human Prescription Drug

**Active ingredient:** BORTEZOMIB

**Strength:** 3.5 mg/1.4mL

**Dosage form:** Injection

**Route:** Intravenous; Subcutaneous

**Labeler:** Shilpa Medicare Limited

**Marketing category:** NDA (NDA212782)

**Pharmacologic class:** Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]